Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2019

Oct 10, 2019

3091_iss_2019-10-10_00af2eb9-1c16-4c36-aa88-3de984bc96d1.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary shares
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 09/10/2019
Limit for number of shares 15 %
Limit for number of votes 15 %
After the transaction
Quantity
Shares 7,420,805
Directly held voting rights 7,420,805
Indirectly held voting rights 0
Percentage
Directly held shares 13.44056 %
Directly held voting rights 13.44056 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 13.44056 % 7,420,805
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 13.44056 % 7,420,805
Group
total
holdings
Voting rights
7,420,805
Percentage of voting rights 13.44056
Published
10/10/2019 11:03
Contact
Name
Jonas Brambeck
Phone
+46708791937 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25